FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

18744211000001103: Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-May 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
64080101000001115 Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
64080201000001110 Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Is a Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has active ingredient Granisetron hydrochloride false Inferred relationship Existential restriction modifier
Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has specific active ingredient Granisetron hydrochloride true Inferred relationship Existential restriction modifier
Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Granisetron true Inferred relationship Existential restriction modifier
Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has basis of strength substance Granisetron true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) 10 tablet Has AMP True Granisetron 1mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start